The Oliver Lab is focused on understanding the biology of under-studied subtypes of lung cancer, specifically squamous and small cell lung cancer (SCLC). We investigate mechanisms of tumor initiation, progression, plasticity, and drug resistance to uncover vulnerabilities that can be therapeutically targeted. We capitalize on state-of-the-art mouse and patient-derived models to identify and test novel treatment strategies, with the goal of translating these findings to the clinic.
Current Appointments & Affiliations
Professor of Pharmacology and Cancer Biology · 2023 - Present Pharmacology & Cancer Biology, Basic Science Departments
Education, Training & Certifications
Duke University · 2005 Ph.D.
Oklahoma Baptist University · 2001 B.S.